| Serial Number | 87468462 |
| Word Mark | NAVICAN PRECISION CANCER CARE |
| Filing Date | Tuesday, May 30, 2017 |
| Status | 710 - CANCELLED - SECTION 8 |
| Status Date | Friday, August 2, 2024 |
| Registration Number | 5384398 |
| Registration Date | Tuesday, January 23, 2018 |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, November 7, 2017 |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Pharmaceutical procurement services, namely, purchasing pharmaceuticals for others; pharmaceutical cost management services and drug utilization review services; assisting patients in enrolling in diagnostics and pharmaceutical reimbursement programs of others; providing business, pricing, reimbursement benchmarking and other market intelligence information in the field of drug reimbursement for prescribers, patients and the pharmaceutical industry; providing business, pricing, reimbursement benchmarking and other market intelligence information in the field of diagnostics reimbursement for providers and patients; business administration of diagnostics and pharmacy reimbursement programs and services; business management and consultation services in the field of specialty pharmacy, namely, assisting patients and providers with pharmaceutical reimbursement; business management and consultation services in the field of off label pharmaceuticals, namely, assisting patients and providers with pharmaceutical reimbursement; business management services in the field of diagnostics, namely, assisting patients and providers with diagnostics reimbursement; promoting collaboration within the scientific, research and medical communities to achieve advances in the fields of healthcare and pharmaceuticals; and business management of comprehensive programs involving drug therapy |
| Goods and Services | Dispensing of pharmaceuticals; medical and pharmaceutical consultation; pharmaceutical advice; pharmaceutical compounding services; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical services, namely, providing personalized drug therapy management programs to cancer patients based on the patient's genetic testing results; genetic testing for medical purposes; genetic testing for cancer diagnosis, treatment and prevention purposes; providing genetic sequencing and consulting services via website designed to provide cancer patients and oncologists with custom tailored information about the range of possible treatments and drug therapies for a particular cancer; providing information to patients and physicians via a website to recommend cancer treatment and drug therapies based on the patient's genetic testing results; providing personalized drug therapy services for cancer patients; drug utilization review dispensing services via a website, namely, identifying cancer drug therapies based on a patient's genetic testing results prior to dispensing medications; developing and managing comprehensive treatment programs involving drug therapy; physician support services in the nature of providing consultation in the dispensing of prescription drugs for persons with particular cancers; providing medical evaluations of patients to determine acceptability for participation in clinical trials; providing healthcare counseling, screening, diagnosis, prognosis, treatment, relapse, palliative, integrative medicine, survivorship, and other related medical information in the field of oncology; providing a database in the field of oncology and featuring inputting and collection of data and information all for treatment and diagnosis purposes; healthcare consultation in the field of cancer treatment research, namely, advising patients on cancer treatment research studies in which they might participate for purposes of treating their conditions; and providing an online searchable database in the fields of oncology, bioinformatics, clinical information technology, genomic data and genomic sequence analysis for personalized diagnosis, treatment and prevention of cancer |
| NOT AVAILABLE | "PRECISION CANCER CARE" |
| Goods and Services | Medical specimen collection kits containing a slide cassette and envelope for collection of cells, tissue, blood, urine, other body fluids and fecal matter |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, August 2, 2024 |
| Primary Code | 010 |
| First Use Anywhere Date | Friday, May 12, 2017 |
| First Use In Commerce Date | Friday, May 12, 2017 |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, August 2, 2024 |
| Primary Code | 035 |
| First Use Anywhere Date | Friday, May 12, 2017 |
| First Use In Commerce Date | Friday, May 12, 2017 |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, August 2, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | Friday, May 12, 2017 |
| First Use In Commerce Date | Friday, May 12, 2017 |
| Party Name | IHC HEALTH SERVICES, INC. |
| Party Type | 31 - New Owner After Registration |
| Legal Entity Type | 54 - NOT AVAILABLE |
| Address | SALT LAKE CITY, UT 84111 |
| Party Name | Navican Genomics, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92130 |
| Party Name | Navican Genomics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92130 |
| Party Name | Navican Genomics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92130 |
| Event Date | Event Description |
| Thursday, August 24, 2017 | EXAMINER'S AMENDMENT ENTERED |
| Friday, June 2, 2017 | NEW APPLICATION ENTERED |
| Tuesday, June 6, 2017 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, August 17, 2017 | ASSIGNED TO EXAMINER |
| Thursday, August 24, 2017 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, August 24, 2017 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, August 24, 2017 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Saturday, September 16, 2017 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, October 18, 2017 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, November 7, 2017 | PUBLISHED FOR OPPOSITION |
| Tuesday, November 7, 2017 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, January 23, 2018 | REGISTERED-PRINCIPAL REGISTER |
| Wednesday, August 14, 2019 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Monday, January 23, 2023 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Friday, August 2, 2024 | CANCELLED SEC. 8 (6-YR) |
| Sunday, October 1, 2017 | ASSIGNED TO LIE |
| Saturday, August 26, 2017 | EXAMINERS AMENDMENT -WRITTEN |
| Saturday, August 26, 2017 | EXAMINERS AMENDMENT E-MAILED |
| Saturday, August 26, 2017 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Saturday, August 26, 2017 | EXAMINER'S AMENDMENT ENTERED |